Protein Kinase C-delta in dopaminergic system and experimental models of Parkinson's disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.31274/rtd-180813-16913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment

  2009cited by this paper
• Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: the importance of receptor phosphorylation and pseudosubstrate sites.

  2007cited by this paper
• Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons

  2007cited by this paper
• Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in Models of Parkinson's Disease and Cognition

  2007cited by this paper
• Neuroprotective Effect of Protein Kinase Cδ Inhibitor Rottlerin in Cell Culture and Animal Models of Parkinson's Disease

  2007cited by this paper
• Kinase signaling pathways: potential therapeutic targets in Parkinson's disease

  2007cited by this paper
• Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons.

  2007cited by this paper
• Clinical research. Testing a novel strategy against Parkinson's disease.

  2007cited by this paper
• Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats.

  2006cited by this paper
• Nuclear localization of the 20S proteasome subunit in Parkinson's disease.

  2006cited by this paper
• Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.

  2006cited by this paper
• Does isoform diversity explain functional differences in the 14-3-3 protein family?

  2006cited by this paper
• Neurodegenerative Diseases: Mechanisms and Therapies

  2006cited by this paper
• Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.

  2006cited by this paper
• Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice.

  2006cited by this paper
• Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.

  2006cited by this paper
• Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

  2006cited by this paper
• Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease.

  2005cited by this paper
• Role of MMP-2 in PKCδ-mediated inhibition of Na+ dependent Ca2+ uptake in microsomes of pulmonary smooth muscle: Involvement of a pertussis toxin sensitive protein

  2005cited by this paper
• Heat Shock Protein 70 Inhibits α-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species*

  2005cited by this paper
• Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

  2005cited by this paper
• Integration of G protein signals by extracellular signal‐regulated protein kinases in SK‐N‐MC neuroepithelioma cells

  2005cited by this paper
• Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells.

  2005cited by this paper
• Clinical trials of coenzyme Q10 in neurological disorders

  2005cited by this paper
• Pramipexole protects against H2O2-induced PC12 cell death

  2005cited by this paper
• Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells.

  2005influential reference
• Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization

  2005cited by this paper
• Roles of Tyrosine Phosphorylation and Cleavage of Protein Kinase Cδ in Its Protective Effect Against Tumor Necrosis Factor-related Apoptosis Inducing Ligand-induced Apoptosis*

  2005cited by this paper
• α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

  2005cited by this paper
• HSP25 inhibits protein kinase C delta-mediated cell death through direct interaction.

  2005cited by this paper
• Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease

  2005cited by this paper
• Activation of protein kinase C delta by proteolytic cleavage contributes to manganese-induced apoptosis in dopaminergic cells: protective role of Bcl-2.

  2005cited by this paper
• In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+

  2005cited by this paper
• Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.

  2005cited by this paper
• Regulation of Amphetamine-stimulated Dopamine Efflux by Protein Kinase C β*

  2005cited by this paper
• Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

  2005cited by this paper
• Protein Kinase Cδ Is a Key Downstream Mediator of Manganese-Induced Apoptosis in Dopaminergic Neuronal Cells

  2005cited by this paper
• KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse.

  2005cited by this paper
• Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration.

  2004influential reference
• A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.

  2004cited by this paper
• Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

  2004cited by this paper
• Multiple Molecular Determinants in the Carboxyl Terminus Regulate Dopamine Transporter Export from Endoplasmic Reticulum*

  2004cited by this paper
• Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.

  2004cited by this paper
• Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment

  2004cited by this paper
• D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade*

  2004cited by this paper
• Regulation of cleavage by protein kinase C in Chaetopterus

  2004cited by this paper
• Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor

  2004cited by this paper
• Regulation of cell apoptosis by protein kinase c δ

  2004influential reference
• S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function

  2004cited by this paper
• Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

  2004cited by this paper
• Manganese toxicokinetics at the blood-brain barrier.

  2004cited by this paper
• Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury.

  2004cited by this paper
• Manganese‐Induced Parkinsonism and Parkinson's Disease

  2004cited by this paper
• Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson’s disease

  2004cited by this paper
• Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2.

  2004influential reference
• Protein Kinase C Mediates Phosphorylation, Desensitization, and Trafficking of the D2 Dopamine Receptor*

  2004cited by this paper
• Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.

  2004cited by this paper
• Diffusion abnormalities of the globi pallidi in manganese neurotoxicity

  2004cited by this paper
• Manganese exposure and induced oxidative stress in the rat brain.

  2004cited by this paper
• Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases

  2004cited by this paper
• Interaction of yeasts with the products resulting from the condensation reaction between (+)-catechin and acetaldehyde.

  2004cited by this paper
• Role of rab5 in EGF receptor-mediated signal transduction.

  2004cited by this paper
• Tyrosine hydroxylase phosphorylation: regulation and consequences

  2004cited by this paper
• A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation.

  2004cited by this paper
• Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites*

  2003cited by this paper
• Identification of Chelerythrine as an Inhibitor of BclXL Function*

  2003cited by this paper
• Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation.

  2003cited by this paper
• N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization*

  2003cited by this paper
• εPKC Is Required for the Induction of Tolerance by Ischemic and NMDA-Mediated Preconditioning in the Organotypic Hippocampal Slice

  2003cited by this paper
• Perspectives on reperfusion-induced damage in rodent models of experimental focal ischemia and role of gamma-protein kinase C.

  2003cited by this paper
• Apoptosis in Parkinson's disease: Signals for neuronal degradation

  2003cited by this paper
• Attenuation of MPTP‐induced dopaminergic neurotoxicity by TV3326, a cholinesterase‐monoamine oxidase inhibitor

  2003cited by this paper
• Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms.

  2003cited by this paper
• Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced Apoptosis

  2003influential reference
• Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration

  2003influential reference
• GIT1 Mediates Src-dependent Activation of Phospholipase Cγ by Angiotensin II and Epidermal Growth Factor*

  2003cited by this paper
• PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.

  2003cited by this paper
• Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.

  2003cited by this paper
• The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines*

  2003cited by this paper
• Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease.

  2003cited by this paper
• Dependence of Gonadotropin-releasing Hormone-induced Neuronal MAPK Signaling on Epidermal Growth Factor Receptor Transactivation*

  2003cited by this paper
• Effect of manganese exposure on MPTP neurotoxicities.

  2003cited by this paper
• Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells.

  2003cited by this paper
• Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s disease

  2003cited by this paper
• Evidence for generation of oxidative stress in brain by MPTP: in vitro and in Research report

  2003cited by this paper
• Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease.

  2003cited by this paper
• Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese.

  2003influential reference
• Conventional protein kinase C isoforms regulate human dopamine transporter activity in Xenopus oocytes

  2002cited by this paper
• Protein kinase C delta (PKC delta): activation mechanisms and functions.

  2002cited by this paper
• Spatial learning is unimpaired in mice containing a deletion of the alpha‐synuclein locus

  2002cited by this paper
• Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

  2002cited by this paper
• Protein kinase C gamma (PKC gamma): function of neuron specific isotype.

  2002cited by this paper
• Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders

  2002cited by this paper
• Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts

  2002cited by this paper
• Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases.

  2002cited by this paper
• Selective enhanced phosphorylation of shrimp beta-tubulin by PKC-delta with PEP(taxol), a synthetic peptide encoding the taxol binding region.

  2002cited by this paper
• Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum*

  2002cited by this paper

• No citing papers are available for this paper.